Custom drug testing: a new way to match RA patients with their ideal treatment

NCT ID NCT06016517

Not yet recruiting Knowledge-focused Sponsor: Tufts Medical Center Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 32 times

Summary

This study aims to learn which rheumatoid arthritis (RA) medication works best for each individual patient by using a personalized N-of-1 trial design. Participants will try up to four FDA-approved RA drugs in a random order and report their symptoms and quality of life through questionnaires. The goal is to improve treatment decisions by understanding how different drugs affect each person's condition. The study involves 18 newly diagnosed adults with moderate to severe RA.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS, RHEUMATOID are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Tufts Medical Center

Boston, Massachusetts, 02111, United States

Conditions

Explore the condition pages connected to this study.

ARTHRITIS, RHEUMATOID